The opportunity extends beyond processing higher sample volumes. The laboratories must provide reliable results, the equipment suppliers must support testing procedures, and customers must be able to use the findings. These expectations are shaping how the market develops and where businesses invest.
Three Trends Moving Cannabis Testing Forward
1. Measurement Consistency Is Becoming a Competitive Priority
For cannabis businesses, testing results are useful when they support repeatable decisions. The manufacturers need to compare batches, assess production changes, and investigate unexpected findings. When measurements are difficult to compare, the businesses face uncertainty about whether differences reflect the product or the testing process.
The National Institute of Standards and Technology’s Cannabis Laboratory Quality Assurance Program, addresses this challenge by helping the laboratories in demonstrating and improving the measurement comparability and competence. Its work shows the importance of dependable testing as the industry develops.
For businesses, this strengthens the case for investing in quality controls, suitable reference materials, and well-documented methods. The laboratories that demonstrate consistent performance can give the customers a stronger basis for decision-making.
This also influences competition. Price and turnaround time remain practical considerations, but customers need confidence that results are meaningful. Providers that combine efficient service with clear reporting and sound testing procedures can build lasting customer relationships.
2. Product Diversity Is Creating Broader Testing Needs
The range of cannabis products creates different questions for laboratories. Flower, oils, concentrates, and infused products can require different preparation procedures and testing methods. Testing capabilities must therefore reflect the products customers actually manufacture.
For instance, Shimadzu’s cannabis testing portfolio covers potency and terpene profiling alongside pesticides, residual solvents, heavy metals, and mycotoxins. This range shows the different testing needs within the industry.
For laboratories, expanding a service portfolio involves more than purchasing additional equipment. Staff must understand the samples, select suitable methods, and interpret findings for the intended application. A procedure suited to one product format may need adjustment before it can serve another reliably.
This creates opportunities for suppliers offering application guidance, training, and technical support. The customers evaluating laboratory investments must consider how effectively the entire testing process will operate.
The market therefore places greater importance on practical capability. The laboratories can serve broader customer needs when their methods, equipment, and personnel develop together, while manufacturers benefit from providers familiar with their particular product categories.
3. Testing Is Becoming Part of Cultivation Decisions
Demand for testing also begins before a finished product exists. Plant-health screening can help cultivators investigate biological threats and make decisions about propagation and crop management.
Medicinal Genomics, for example, offers an RT-qPCR assay that screens cannabis leaves and roots for hop latent viroid. This provides an example of molecular testing within cultivation operations.
For growers, the business value lies in receiving information early enough to take action. The testing providers serving this application need sampling procedures, reporting formats, and service schedules suited to cultivation activities.
This broadens the relationship between laboratories and producers. Instead of interacting only when a finished batch requires analysis, providers can support recurring operational needs. Cultivation screening therefore creates another business opportunity, particularly for specialists that understand both molecular methods and growing environments.
Together, these three trends show why cannabis testing demand comes from several stages of production. Understanding those stages helps explain the market’s segmentation.
How Market Segmentation Connects Services, Equipment, and Customers
- By service type, CMI segments the market into potency testing, residual solvent testing, mycotoxin testing, microbial testing, genetic testing, heavy metal testing, pesticide screening, and others.
- By product type, the report covers analytical instruments, including chromatography and spectroscopy, along with a combined category for consumables, testing software and services, and a separate category for breath analyzers.
- By end user, the report includes cannabis drug manufacturers, cannabis cultivators and growers, research institutes and laboratories, and others.
These categories represent connected purchasing decisions. A manufacturer may purchase an outsourced testing service, while the laboratory providing it purchases instruments and consumables. A grower may require plant-health screening, while researchers need testing equipment for experimental work.
This relationship matters because demand for one activity can support another. A laboratory expanding its testing portfolio may need additional equipment, reference materials, or training. A manufacturer introducing a formulation may require testing support during development and subsequent production.
Potency testing and analytical instruments show this connection particularly well. Potency testing represents a recurring service requirement, while analytical instruments provide the equipment needed to deliver it.
Potency Testing: Making Product Composition Useful for Businesses
Potency testing is estimated to account for 26.5% of the global cannabis testing market in 2026, making it the leading service category in CMI’s assessment.
Its importance comes from the need to understand cannabinoid concentrations in products and production materials. This information supports the formulation decisions, batch comparisons, and product descriptions.
The analysis can extend beyond a single THC measurement. Shimadzu has documented an HPLC method for determining 15 cannabinoids, showing the level of detail available through suitable testing methods.
For manufacturers, an important reason for adoption is the need to achieve intended formulations consistently. A business producing cannabinoid-containing oil needs information about its starting material before deciding how to formulate the finished product. Subsequent analysis can help assess whether production achieved the expected composition.
In a market where authenticity is vital, product descriptions gain value when businesses can support them with evidence. Cannaflower’s emphasis on laboratory-tested CBD hemp flower shows how testing can become part of the way a brand presents its products to customers.
Analytical Instruments: Building the Capacity Behind Market Expansion
Delivering these services requires suitable laboratory equipment. Analytical instruments are estimated to account for 46.5% of the global cannabis testing market in 2026, making them CMI’s largest product category.
Chromatography plays an important role within this category. Shimadzu identifies high-performance liquid chromatography as a widely used technique for cannabinoid analysis and offers dedicated cannabis and hemp analyzers.
The instrument adoption depends on the laboratory’s intended services, expected workload, and required testing performance. A facility focused on cannabinoid measurement will make different investment decisions from one developing a broader contaminant-testing portfolio.
Applications extend to elemental analysis as well. Agilent describes cannabis testing methods for arsenic, cadmium, lead, and mercury, thus showing how analytical systems support investigations beyond product potency.
For laboratory operators, equipment selection is a business decision as well as a technical one. Acquisition price must be considered alongside throughput, maintenance, staff training, method suitability, and service support. Equipment creates business value when it fits the samples and workload the laboratory expects to handle.
The U.S. Market: State-Level Developments Shape Demand
The U.S. shows how local regulatory developments influence testing requirements. California has required licensed laboratories to use standardized cannabinoid methods for dried flower and non-infused pre-rolls since January 1, 2024. This reinforces demand for consistent procedures and proper use of testing methods.
Access to medical cannabis also shapes market demand. The readers researching Virginia’s official state requirements can consult CannabisMD TeleMed’s explanatory guide alongside Virginia Cannabis Control Authority guidance. Virginia’s move to electronic medical cannabis certifications, beginning December 1, 2025, shows how patient-access systems are developing.
For testing providers, these developments suggest opportunities connected with regulated product sales and dependable testing services. The adoption depends on the understanding local customer needs and providing suitable capabilities. Laboratories must consider the jurisdictions they serve, while suppliers need to support the procedures and applications used within those markets.
Competition Spans Laboratory Services and Testing Technology
The demand described above supports several types of market participants. CMI identifies companies including SC Labs, Anresco, Eurofins Scientific, Agilent Technologies, Shimadzu Scientific Instruments, and Restek.
Their competitive priorities vary according to their roles. The laboratory service providers need to manage samples efficiently, maintain testing quality, and deliver reports customers can use. Equipment and consumables suppliers must provide systems that fit laboratory applications and remain practical to operate.
Agilent’s cannabis portfolio covers testing procedures for potency, pesticides, residual solvents, metals, and terpenes. This range shows how suppliers can support laboratories developing multiple testing services.
Meanwhile, molecular-testing specialists address cultivation applications, creating another area of competition around plant-health information.
Across these activities, standing out depends on understanding customer decisions. The manufacturers need information relevant to production, growers need findings they can use in cultivation, and laboratory operators need equipment that supports dependable service delivery. Businesses that connect their technical capabilities with these needs have a clearer basis for building customer relationships.
Market Outlook: Turning Testing Capability into Lasting Value
The cannabis testing market’s growth opportunity rests on the expanding need for reliable information throughout production and sales. That demand supports laboratory services, analytical equipment, recurring consumables, and specialist cultivation applications.
Making the most of this opportunity requires careful investment. The laboratories must balance service expansion with operational capacity, while suppliers need to support the applications customers actually perform. Clear reporting also matters because a technically sound result creates value when the customer understands its implications.
